Stem cell therapy: A hope for dying hearts

Stem Cells and Development

Volumn 16, Issue 4, 2007, Pages 517-536

  Sharma, Rishi ^a   Raghubir, Ram ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DIFFERENTIATION; CELL FUSION; CELL ISOLATION; CELL PROLIFERATION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REGENERATION;

CELL FUSION; EMBRYONIC STEM CELLS; HEART FAILURE; HUMANS; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION;

ANIMALIA;

EID: 34548510573     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.0070     Document Type: Review

References (276)

1. Hunt SA. (1998). Current status of cardiac transplantation. J Am Med Assn 280:1692-1698.
2. Chiu RC, A Zibaitis and RL Kao. (1995). Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 60:12-18.
3. American Heart Association. (2003). Heart disease and stroke statistics - 2004 update. American Heart Association, Dallas, TX.
4. Li RK, ZQ Jia, RD Weisel, DA Mickle, J Zhang, MK Mohabeer, V Rao and J Ivanov. (1996). Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 62:654-660.
5. Beltrami AP K Urbanek, J Kajstura, SM Yan, N Finato, R Bussani, B Nadal-Ginard, F Silvestri, A Led, CA Beltrami and P Anversa. (2001). Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344:1750-1757.
6. Anversa P and B Nadal-Ginard. (2002). Myocyte renewal and ventricular remodelling. Nature 415:240-243.
7. Menasche P. (2003). Stem cells: where we stand. Dialogues Cardiovasc Med 8:123-133.
8. Reffelmann T and RA Kloner. (2005). Cellular cardiomyoplasty - cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res 58:358-368.
9. Kehat I, D Kenyagin-Karsenti, M Snir, H Segev, M Amit, A Gepstein, E Livne, O Binah, J Itskovitz-Eldor and L Gepstein. (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108:407-414.
10. Makino S, K Fukuda, S Miyoshi, F Konishi, H Kodama, J Pan, M Sano, T Takahashi, S Hori, H Abe, J Hata, A Umezawa and S Ogawa. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103:697-705.
11. Toma C, MF Pittenger, KS Cahill, BJ Byrne and PD Kessler. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93-98.
12. Taylor DA, BZ Atkins, P Hungspreugs, TR Jones, MC Reedy, KA Hutcheson, DD Glower and WE Kraus. (1998). Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nature Med 4:929-933.
13. Hwang WS, YJ Ryu, JH Park, ES Park, EG Lee, JM Koo, HY Jeon, BC Lee, SK Kang, SJ Kim, C Ahn, JH Hwang, KY Park, JB Cibelli and SY Moon. (2004). Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 303:1669-1674.
14. Herszfeld D, E Wolvetang, E Langton-Bunker, TL Chung, AA Filipczyk, S Houssami, P Jamshidi, K Koh, AL Laslett, A Michalska, L Nguyen, BE Reubinoff, I Tellis, JM Auerbach, CJ Ording, LH Looijenga and MF Pera. (2006). CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nature Biotechnol 24:351-357.
15. Reubinoff BE, MF Pera, CY Fong, A Trounson and A Bongso. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nature Biotechnol 18:399-404.
16. Fuhrmann G, AC Chung, KJ Jackson, G Hummelke, A Baniahmad, J Sutter, I Sylvester, HR Scholer and AJ Cooney. (2001). Mouse germline restriction of Oct4 expression by germ cell nuclear factor. Dev Cell 1:377-387.
17. Gerrard L, D Zhao, AJ Clark and W Cui. (2005). Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency. Stem Cells 23:124-133.
18. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
19. Berstine EG, ML Hooper, S Grandchamp and B Ephrussi. (1973). Alkaline phosphatase activity in mouse teratoma. Proc Natl Acad Sci USA 70:3899-3903.
20. Latza U, HD Foss, H Durkop, F Eitelbach, KP Dieckmann, V Loy, M Unger, G Pizzolo and H Stein. (1995). CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule. Am J Pathol 146:463-471.
21. Schopperle WM, DB Kershaw and WC DeWolf. (2003). Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin. Biochem Biophys Res Commun 300:285-290.
22. Przyborski S A. (2001). Isolation of human embryonal carcinoma stem cells by immunomagnetic sorting. Stem Cells 19:500-504.
23. Andrews PW, I Damjanov, D Simon, GS Banting, C Carlin, NC Dracopoli and J Fogh. (1984). Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 50:147-162.
24. Beauchamp JR, L Heslop, DS Yu, S Tajbakhsh, RG Kelly, A Wernig, ME Buckingham, TA Partridge and PS Zammit. (2000). Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 151:1221-1234.
25. He KL, GH Yi, W Sherman, H Zhou, GP Zhang, A Gu, R Kao, HB Haimes, J Harvey, E Roos, D White, DA Taylor, J Wang and D Burkhoff. (2005). Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs. J Heart Lung Transplant 24:1940-1949.
26. Weintraub H, VJ Dwarki, I Verma, R Davis, S Hollenberg, L Snider, A Lassar and SJ Tapscott. (1991). Muscle-specific transcriptional activation by MyoD. Genes Dev 5:1377-1386.
27. Reimann J, K Brimah, R Schroder, A Wernig, JR Beauchamp and TA Partridge. (2004). Pax7 distribution in human skeletal muscle biopsies and myogenic tissue cultures. Cell Tissue Res 315:233-242.
28. Ludolph DC and SF Konieczny. (1995). Transcription factor families: muscling in on the myogenic program. FASEB J 9:1595-1604.
29. Herring BP, S Dixon and PJ Gallagher. (2000). Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. Am J Physiol Cell Physiol 279:C1656-C1664.
30. Ziegler BL, M Valtieri, GA Porada, R De Maria, R Muller, B Masella, M Gabbianelli, I Casella, E Pelosi, T Bock, ED Zanjani and C Peschle. (1999). KDR receptor: a key marker defining hematopoietic stem cells. Science 285: 1553-1558.
31. Ikuta K and IL Weissman. (1992). Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA 89:1502-1506.
32. Gallacher L, B Murdoch, DM Wu, FN Karanu, M Keeney and M Bhatia. (2000). Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 95:2813-2820.
33. Spangrude GJ, S Heimfeld and IL Weissman. (1988). Purification and characterization of mouse hematopoietic stem cells. Science 241:58-62.
34. Wolfram O, K Jentsch-Ullrich, A Wagner, M Hammwohner, R Steinke, A Franke, I Zupan, HU Klein and A Goette. (2007). G-CSF-induced mobilization of CD34 progenitor cells and proarrhythmic effects in patients with severe coronary artery disease. Pacing Clin Electrophysiol 30(Suppl 1):S166-S169.
35. Robert B, PL St. John and DR Abrahamson. (1998). Direct visualization of renal vascular morphogenesis in Flk1 heterozygous mutant mice. Am J Physiol 275:F164-F172.
36. Heeschen C, A Aicher, R Lehmann, S Fichtlscherer, M Vasa, C Urbich, C Mildner-Rihm, H Martin, AM Zeiher and S Dimmeler. (2003). Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102:1340-1346.
37. Werner N, S Kosiol, T Schiegl, P Ahlers, K Walenta, A Link, M Bohm and G Nickenig. (2005). Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999-1007.
38. Chen D, X Ji, MA Harris, JQ Feng, G Karsenty, AJ Celeste, V Rosen, GR Mundy and SE Harris. (1998). Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142:295-305.
39. Gronthos S, SE Graves, S Ohta and PJ Simmons. (1994). The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 84:4164-4173.
40. Urbanek K, M Rota, S Cascapera, C Bearzi, A Nascimbene, A De Angelis, T Hosoda, S Chimenti, M Baker, F Limana, D Nurzynska, D Torella, F Rotatori, R Rastaldo, E Musso, F Quaini, A Leri, J Kajstura and P Anversa. (2005). Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 97:663-673.
41. Xu C, G Liguori, ED Adamson and MG Persico. (1998). Specific arrest of cardiogenesis in cultured embryonic stem cells lacking Cripto-1. Dev Biol 196:237-247.
42. Yamada Y, SI Yokoyama, XD Wang, N Fukuda and N Takakura. (2007). Cardiac stem cells in brown adipose tissue express CD133 and induce bone marrow non-hematopoietic cells to differentiate into cardiomyocytes. Stem Cells 25:1326-1333.
43. Anversa P, J Kajstura, A Leri and R Bolli. (2006). Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 113:1451-1463.
44. Nagai T, I Shiojima, K Matsuura and I Komuro. (2005). Promotion of cardiac regeneration by cardiac stem cells. Circ Res 97:615-617.
45. Gepstein L. (2002). Derivation and potential applications of human embryonic stem cells. Circ Res 91:866-876.
46. Thomson JA, J Kalishman, TG Golos, M Durning, CP Harris and JP Hearn. (1996). Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts. Biol Reprod 55:254-259.
47. Reubinoff BE, MF Pera, G Vajta and AO Trounson. (2001). Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod 16:2187-2194.
48. Gropp M, P Itsykson, O Singer, T Ben Hur, E Reinhartz, E Galun and BE Reubinoff. (2003). Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol Ther 7:281-287.
49. Ben-Dor I, P Itsykson, D Goldenberg, E Galun and BE Reubinoff. (2006). Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells. Mol Ther 14:255-267.
50. Doetschman TC, H Eistetter, M Katz, W Schmidt and R Kemler. (1985). The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87:27-45.
51. 2+ channel blockers. Differentiation 48:173-182.
52. Bishop AE, LD Buttery and JM Polak. (2002). Embryonic stem cells. J Pathol 197:424-429.
53. Kawasaki H, H Suemori, K Mizuseki, K Watanabe, F Urano, H Ichinose, M Haruta, M Takahashi, K Yoshikawa, S Nishikawa, N Nakatsuji and Y Sasai. (2002). Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc Natl Acad Sci USA 99:1580-1585.
54. Savatier P, H Lapillonne, LA van Grunsven, BB Rudkin, and J Samarut. (1996). Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene 12:309-322.
55. Itsykson P, N Ilouz, T Turetsky, RS Goldstein, MF Pera, 1 Fishbein, M Segal and BE Reubinoff. (2005). Derivation of neural precursors from human embryonic stem cells in the presence of noggin. Mol Cell Neurosci 30:24-36.
56. Thomson JA and VS Marshall. (1998). Primate embryonic stem cells. Curr Top Dev Biol 38:133-165.
57. + cells at a diverging point of endothelial and hemopoietic lineages. Development 125:1747-1757.
58. Tropepe V, S Hitoshi, C Sirard, TW Mak, J Rossant and D van der Kooy. (2001). Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 30:65-78.
59. Xu C, MS Inokuma, J Denham, K Golds, P Kundu, JD Gold and MK Carpenter. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nature Biotechnol 19:971-974.
60. Richards M, CY Fong, WK Chan, PC Wong and A Bongso. (2002). Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nature Biotechnol 20:933-936.
61. Amit M, V Margulets, H Segev, K Shariki, I Laevsky, R Coleman and J Itskovitz-Eldor. (2003). Human feeder layers for human embryonic stem cells. Biol Reprod 68:2150-2156.
62. Amit M, C Shariki, V Margulets and J Itskovitz-Eldor. (2004). Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 70:837-845.
63. Sato N, L Meijer, L Skaltsounis, P Greengard and AH Brivanlou. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nature Med 10:55-63.
64. Genbacev O, A Krtolica, T Zdravkovic, E Brunette, S Powell, A Nath, E Caceres, M McMaster, S McDonagh, Y Li, R Mandalam, J Lebkowski and SJ Fisher. (2005). Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. Fertil Steril 83:1517-1529.
65. Xu C, E Rosier, J Jiang, JS Lebkowski, JD Gold, C O'Sullivan, K Delavan-Boorsma, M Mok, A Bronstein and MK Carpenter. (2005). Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells 23:315-323.
66. Ludwig TE, V Bergendahl, ME Levenstein, J Yu, MD Probasco and JA Thomson. (2006). Feeder-independent culture of human embryonic stem cells. Nature Methods 3:637-646.
67. Schuldiner M, O Yanuka, J Itskovitz-Eldor, DA Melton and N Benvenisty. (2000). Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 97:11307-11312.
68. Dani C, AG Smith, S Dessolin, P Leroy, L Staccini, P Villageois, C Darimont and G Ailhaud. (1997). Differentiation of embryonic stem cells into adipocytes in vitro. J Cell Sci 110(Pt 11):1279-1285.
69. Fraichard A, O Chassande, G Bilbaut, C Dehay, P Savatier and J Samarut. (1995). In vitro differentiation of embryonic stem cells into glial cells and functional neurons. J Cell Sci 108(Pt 10):3181-3188.
70. Maltsev VA, J Rohwedel, J Hescheler and AM Wobus. (1993). Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev 44:41-50.
71. Kramer J, M Klinger, C Kruse, M Faza, G Hargus and J Rohwedel. (2005). Ultrastructural analysis of mouse embryonic stem cell-derived chondrocytes. Anat Embryol (Berl) 210:175-185.
72. Wiles MV and G Keller. (1991). Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 111:259-267.
73. Fairchild PJ, FA Brook, RL Gardner, L Graca, V Strong, Y Tone, M Tone, KF Nolan and H Waldmann. (2000). Directed differentiation of dendritic cells from mouse embryonic stem cells. Curr Biol 10:1515-1518.
74. Risau W, H Sariola, HG Zerwes, J Sasse, P Ekblom, R Kemler and T Doetschman. (1988). Vasculogenesis and angiogenesis in embryonic-stem-cell- derived embryoid bodies. Development 102:471-478.
75. Bagutti C, AM Wobus, R Fassler and FM Watt. (1996). Differentiation of embryonal stem cells into keratinocytes: comparison of wild-type and beta 1 integrin-deficient cells. Dev Biol 179:184-196.
76. Potocnik AJ, PJ Nielsen and K Eichmann. (1994). In vitro generation of lymphoid precursors from embryonic stem cells. EMBO J 13:5274-5283.
77. Tsai M, J Wedemeyer, S Ganiatsas, SY Tarn, LI Zon and SJ Galli. (2000). In vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo. Proc Natl Acad Sci USA 97:9186-9190.
78. Bain G, D Kitchens, M Yao, JE Huettner and DI Gottlieb. (1995). Embryonic stem cells express neuronal properties in vitro. Dev Biol 168:342-357.
79. Strubing C, G Ahnert-Hilger, J Shan, B Wiedenmann, J Hescheler and AM Wobus. (1995). Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro gives rise to mature inhibitory and excitatory neurons. Mech Dev 53:275-287.
80. Brustle O, KN Jones, RD Learish, K Karram, K Choudhary, OD Wiestler, ID Duncan and RD McKay. (1999). Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 285:754-756.
81. Liu S, Y Qu, TJ Stewart, MJ Howard, S Chakrabortty, TF Holekamp and JW McDonald. (2000). Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci USA 97:6126-6131.
82. Buttery LD, S Bourne, JD Xynos, H Wood, FJ Hughes, SP Hughes, V Episkopou and JM Polak. (2001). Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng 7:89-99.
83. Lumelsky N, O Blondel, P Laeng, I Velasco, R Ravin and R McKay. (2001). Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:1389-1394.
84. Soria B, E Roche, G Berna, T Leon-Quinto, JA Reig and F Martin. (2000). Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49:157-162.
85. Yamashita J, H Itoh, M Hirashima, M Ogawa, S Nishikawa, T Yurugi, M Naito, K Nakao and S Nishikawa. (2000). Flk1-positive cells derived from embry onic stem cells serve as vascular progenitors. Nature 408:92-96.
86. Rohwedel J, V Maltsev, E Bober, HH Arnold, J Hescheler and AM Wobus. (1994). Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev Biol 164:87-101.
87. Yamane T, S Hayashi, M Mizoguchi, H Yamazaki and T Kunisada. (1999). Derivation of melanocytes from embryonic stem cells in culture. Dev Dyn 216:450-458.
88. Hamazaki T, Y Iiboshi, M Oka, PJ Papst, AM Meacham, LI Zon and N Terada. (2001). Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS Lett 497:15-19.
89. Jones EA, D Tosh, DI Wilson, S Lindsay and LM Forrester. (2002). Hepatic differentiation of murine embryonic stem cells. Exp Cell Res 272:15-22.
90. Ali NN, AJ Edgar, A Samadikuchaksaraei, CM Timson, HM Romanska, JM Polak and AE Bishop. (2002). Derivation of type II alveolar epithelial cells from murine embryonic stem cells. Tissue Eng 8:541-550.
91. Kaufman DS, ET Hanson, RL Lewis, R Auerbach and JA Thomson. (2001). Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 98:10716-10721.
92. Assady S, G Maor, M Amit, J Itskovitz-Eldor, KL Skorecki and M Tzukerman. (2001). Insulin production by human embryonic stem cells. Diabetes 50:1691-1697.
93. McDonald JW, XZ Liu, Y Qu, S Liu, SK Mickey, D Turetsky, DI Gottlieb and DW Choi. (1999). Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nature Med 5:1410-1412.
94. Odorico JS, DS Kaufman and JA Thomson. (2001). Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19:193-204.
95. Levenberg S, JS Golub, M Amit, J Itskovitz-Eldor and R Langer. (2002). Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99: 4391-4396.
96. Klug MG, MH Soonpaa, GY Koh and LJ Field. (1996). Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 98:216-224.
97. Li M, L Pevny, R Lovell-Badge and A Smith. (1998). Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol 8:971-974.
98. Muller M, BK Fleischmann, S Selbert, GJ Ji, E Endl, G Middeler, OJ Muller, P Schlenke, S Frese, AM Wobus, J Hescheler, HA Katus and WM Franz. (2000). Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 14:2540-2548.
99. Schindehutte J, H Fukumitsu, P Collombat, G Griesel, C Brink, PC Baier, MR Capecchi and A Mansouri. (2005). In vivo and in vitro tissue-specific expression of green fluorescent protein using the cre-lox system in mouse embryonic stem cells. Stem Cells 23:10-15.
100. Mountford P, J Nicholus, B Zevnik, C O'Brein, and A Smith. (1998). Maintenance of pluripotential embryonic stem cells by stem cell selection. Reprod Fertil Dev 10:527-533.
101. Eiges R, M Schuldiner, M Drukker, O Yanuka, J Itskovitz-Eldor and N Benvenisty. (2001). Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol 11:514-518.
102. Weintraub H, R Davis, S Tapscott, M Thayer, M Krause, R Benezra, TK Blackwell, D Turner, R Rupp, S Hollenberg, Y Zhuang and A Lassar. (1991). The myoD gene family: Nodal point during specification of the muscle cell lineage. Science 251:761-766.
103. Dekel I, Y Magal, S Pearson-White, CP Emerson and M Shani. (1992). Conditional conversion of ES cells to skeletal muscle by an exogenous MyoD1 gene. New Biol 4:217-224.
104. Levinson-Dushnik M and N Benvenisty. (1997). Involvement of hepatocyte nuclear factor 3 in endoderm differentiation of embryonic stem cells. Mol Cell Biol 17:3817-3822.
105. Hescheler J, BK Fleischmann, S Lentini, VA Maltsev, J Rohwedel, AM Wobus and K Addicks. (1997). Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis. Cardiovasc Res 36:149-162.
106. Soonpaa MH, GY Koh, MG Klug and LJ Field. (1994). Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264:98-101.
107. Koh GY, MH Soonpaa, MG Klug, HP Pride, BJ Cooper, DP Zipes and LJ Field. (1995). Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest 96:2034-2042.
108. Li RK, DA Mickle, RD Weisel, MK Mohabeer, J Zhang, V Rao, G Li, F Merante and ZQ Jia. (1997). Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation 96:11-86.
109. Matsushita T, M Oyamada, H Kurata, S Masuda, A Takahashi, T Emmoto, I Shiraishi, Y Wada, T Oka and T Takamatsu. (1999). Formation of cell junctions between grafted and host cardiomyocytes at the border zone of rat myocardial infarction. Circulation 100: II262-II268.
110. Scorsin M, AA Hagege, I Dolizy, F Marotte, N Mirochnik, H Copin, M Barnoux, M le Bert, JL Samuel, L Rappaport and P Menasche. (1998). Can cellular transplantation improve function in doxorubicin-induced heart failure? Circulation 98:11151-11155.
111. Etzion S, A Battler, IM Barbash, E Cagnano, P Zarin, Y Granot, LH Kedes, RA Kloner and J Leor. (2001). Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol 33:1321-1330.
112. Weissman IL. (2002). Stem cells - scientific, medical, and political issues. N Engl J Med 346:1576-1579.
113. Gearhart J. (1998). New potential for human embryonic stem cells. Science 282:1061-1062.
114. Evans MJ and MH Kaufman. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156.
115. Wilmut I, N Beaujean, PA de Sousa, A Dinnyes, TJ King, LA Paterson, DN Wells and LE Young. (2002). Somatic cell nuclear transfer. Nature 419:583-586.
116. Chambers I, D Colby, M Robertson, J Nichols, S Lee, S Tweedie and A Smith. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643-655.
117. Chen S, Q Zhang, X Wu, PG Schultz and S Ding. (2004). Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc 126:410-411.
118. Do JT and HR Scholer. (2004). Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 22:941-949.
119. Eggan K, H Akutsu, K Hochedlinger, W Rideout, III, R Yanagimachi and R Jaenisch. (2000). X-Chromosome inactivation in cloned mouse embryos. Science 290: 1578-1581.
120. Flasza M, AF Shering, K Smith, PW Andrews, P Talley and PA Johnson. (2003). Reprogramming in inter-species embryonal carcinoma-somatic cell hybrids induces expression of pluripotency and differentiation markers. Cloning Stem Cells 5:339-354.
121. Hakelien AM, HB Landsverk, JM Robl, BS Skalhegg and P Collas. (2002). Reprogramming fibroblasts to express T-cell functions using cell extracts. Nature Biotechnol 20:460-466.
122. Harris RG, EL Herzog, EM Bruscia, JE Grove, JS Van Arnam and DS Krause. (2004). Lack of a fusion requirement for development of bone marrow-derived epithelia. Science 305:90-93.
123. Hatano SY, M Tada, H Kimura, S Yamaguchi, T Kono, T Nakano, H Suemori, N Nakatsuji and T Tada. (2005). Pluripotential competence of cells associated with Nanog activity. Mech Dev 122:67-79.
124. Kimura H, M Tada, N Nakatsuji and T Tada. (2004). Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol Cell Biol 24:5710-5720.
125. Landsverk HB, AM Hakelien, T Kuntziger, JM Robl, BS Skalhegg and P Collas. (2002). Reprogrammed gene expression in a somatic cell-free extract. EMBO Rep 3:384-389.
126. Matveeva NM, AG Shilov, EM Kaftanovskaya, LP Maximovsky, AI Zhelezova, AN Golubitsa, SI Bayborodin, MM Fokina and OL Serov. (1998). In vitro and in vivo study of pluripotency in intraspecific hybrid cells obtained by fusion of murine embryonic stem cells with splenocytes. Mol Reprod Dev 50:128-138.
127. McGann CJ, SJ Odelberg and MT Keating. (2001). Mammalian myotube dedifferentiation induced by newt regeneration extract. Proc Natl Acad Sci USA 98:13699-13704.
128. Mitsui K, Y Tokuzawa, H Itoh, K Segawa, M Murakami, K Takahashi, M Maruyama, M Maeda and S Yamanaka. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:631-642.
129. Nichols J, B Zevnik, K Anastassiadis, H Niwa, D Klewe-Nebenius, I Chambers, H Scholer and A Smith. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391.
130. Pells S, AI Di Domenico, EJ Gallagher and J McWhir. (2002). Multipotentiality of neuronal cells after spontaneous fusion with embryonic stem cells and nuclear reprogramming in vitro. Cloning Stem Cells 4:331-338.
131. Shi W, V Zakhartchenko and E Wolf. (2003). Epigenetic reprogramming in mammalian nuclear transfer. Differentiation 71:91-113.
132. Tada M, T Tada, L Lefebvre, SC Barton and MA Surani. (1997). Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J 16:6510-6520.
133. Tada M, Y Takahama, K Abe, N Nakatsuji and T Tada. (2001). Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11:1553-1558.
134. Tada M, A Morizane, H Kimura, H Kawasaki, JF Ainscough, Y Sasai, N Nakatsuji and T Tada. (2003). Pluripotency of reprogrammed somatic genomes in embryonic stem hybrid cells. Dev Dyn 227:504-510.
135. Terada N, T Hamazaki, M Oka, M Hoki, DM Mastalerz, Y Nakano, EM Meyer, L Morel, BE Petersen and EW Scott. (2002). Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416: 542-545.
136. Wilmut I, AE Schnieke, J McWhir, AJ Kind and KH Campbell. (1997). Viable offspring derived from fetal and adult mammalian cells. Nature 385:810-813.
137. Ying QL, J Nichols, EP Evans and AG Smith. (2002). Changing potency by spontaneous fusion. Nature 416:545-548.
138. Till JE and EA McCulloch. (1961). A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14:213-222.
139. Becker AJ, EA McCulloch and JE Till. (1963). Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 197:452-454.
140. Gage FH, PW Coates, TD Palmer, HG Kuhn, LJ Fisher, JO Suhonen, DA Peterson, ST Suhr and J Ray. (1995). Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci USA 92:11879-11883.
141. Johe KK, TG Hazel, T Muller, MM Dugich-Djordjevic and RD McKay. (1996). Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev 10:3129-3140.
142. McKay R. (1997). Stem cells in the central nervous system. Science 276:66-71.
143. Weiss S and D van der Kooy. (1998). CNS stem cells: where's the biology (a.k.a. beef)? J Neurobiol 36:307-314.
144. Shihabuddin LS, TD Palmer and FH Gage. (1999). The search for neural progenitor cells: prospects for the therapy of neurodegenerative disease. Mol Med Today 5:474-480.
145. Temple S and A Alvarez-Buylla. (1999). Stem cells in the adult mammalian central nervous system. Curr Opin Neurobiol 9:135-141.
146. Momma S, CB Johansson and J Frisen. (2000). Get to know your stem cells. Curr Opin Neurobiol 10:45-49.
147. Mauro A. (1961). Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9:493-495.
148. Slack JM. (2000). Stem cells in epithelial tissues. Science 287:1431-1433.
149. Sell S. (1990). Is there a liver stem cell? Cancer Res 50:3811-3815.
150. Thorgeirsson SS. (1993). Hepatic stem cells. Am J Pathol 142:1331-1333.
151. Germain L, M Noel, H Gourdeau and N Marceau. (1988). Promotion of growth and differentiation of rat ductular oval cells in primary culture. Cancer Res 48:368-378.
152. Sirica AE, GA Mathis, N Sano and LW Elmore. (1990). Isolation, culture, and transplantation of intrahepatic biliary epithelial cells and oval cells. Pathobiology 58:44-64.
153. Ghazizadeh S and LB Taichman. (2001). Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin. EMBO J 20:1215-1222.
154. Kuehnle I and MA Goodell. (2002). The therapeutic potential of stem cells from adults. Br Med J 325:372-376.
155. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, M Blackstad, J Du, S Aldrich, A Lisberg, WC Low, DA Largaespada and CM Verfaillie. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
156. Orlic D, J Kajstura, S Chimenti, I Jakoniuk, SM Anderson, B Li, J Pickel, R McKay, B Nadal-Ginard, DM Bodine, A Leri and P Anversa. (2001). Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705.
157. Campion DR. (1984). The muscle satellite cell: a review. Int Rev Cytol 87:225-251.
158. Germani A, A Di Carlo, A Mangoni, S Straino, C Giacinti, P Turrini, P Biglioli and MC Capogrossi. (2003). Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol 163:1417-1428.
159. Marelli D, C Desrosiers, M el Alfy, RL Kao and RC Chiu. (1992). Cell transplantation for myocardial repair: an experimental approach. Cell Transplant 1:383-390.
160. Kessler PD and BJ Byrne. (1999). Myoblast cell grafting into heart muscle: cellular biology and potential applications. Annu Rev Physiol 61:219-242.
161. Suzuki K, NJ Brand, RT Smolenski, J Jayakumar, B Murtuza and MH Yacoub. (2000). Development of a novel method for cell transplantation through the coronary artery. Circulation 102:111359-111364.
162. Blau HM and C Webster. (1981). Isolation and characterization of human muscle cells. Proc Natl Acad Sci USA 78:5623-5627.
163. Rubart M, MH Soonpaa, H Nakajima and LJ Field. (2004). Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest 114:775-783.
164. Murtuza B, K Suzuki, G Bou-Gharios, JR Beauchamp, RT Smolenski, TA Partridge and MH Yacoub. (2004). Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci USA 101:4216-4221.
165. Menasche P, AA Hagege, M Scorsin, B Pouzet, M Desnos, D Duboc, K Schwartz, JT Vilquin and JP Marolleau. (2001). Myoblast transplantation for heart failure. Lancet 357:279-280.
166. Herreros J, F Prosper, A Perez, JJ Gavira, MJ García-Velloso, J Barba, PL Sanchez, C Canizo, G Rabago, JM Marti-Climent, M Hernandez, N Lopez-Holgado, JM Gonzalez-Santos, C Martin-Luengo and E Alegria. (2003). Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24:2012-2020.
167. Vazquez ME, MR Cabarcos, TD Roman, AJ Stein, ND Garcia, BA Nazar, MJ Dopico, CA Nunez and FJ Garcia. (2005). Cellular cardiomyoplasty: development of a technique to culture human myoblasts for clinical transplantation. Cell Tissue Bank 6:117-124.
168. Dib N, P McCarthy, A Campbell, M Yeager, FD Pagani, S Wright, WR
169. Gavira JJ, J Herreros, A Perez, MJ Garcia-Velloso, J Barba, F Martin-Herrero, C Canizo, A Martin-Arnau, JM Marti-Climent, M Hernandez, N Lopez-Holgado, JM Gonzalez-Santos, C Martin-Luengo, E Alegria and F Prosper. (2006). Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg 131:799-804.
170. Haider HK, AC Tan, S Aziz, JC Chachques and EK Sim. (2004). Myoblast transplantation for cardiac repair: a clinical perspective. Mol Ther 9:14-23.
171. Dib N, RE Michler, FD Pagani, S Wright, DJ Kereiakes, R Lengerich, P Binkley, D Buchele, I Anand, C Swingen, MF Di Carli, JD Thomas, WA Jaber, SR Opie, A Campbell, P McCarthy, M Yeager, V Dilsizian, BP Griffith, R Korn, SK Kreuger, M Ghazoul, WR MacLellan, G Fonarow, HJ Eisen, J Dinsmore and E Diethrich. (2005). Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112:1748-1755.
172. Ince H, M Petzsch, TC Rehders, S Kische, T Chatterjee and CA Nienaber. (2005). [Percutaneous transplantation of autologous myoblasts in ischemic cardiomyopathy.]. Herz 30:223-231.
173. Pagani FD, H DerSimonian, A Zawadzka, K Wetzel, AS Edge, DB Jacoby, JH Dinsmore, S Wright, TH Aretz, HJ Eisen and KD Aaronson. (2003). Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41:879-888.
174. Ince H, M Petzsch, TC Rehders, T Chatterjee and CA Nienaber. (2004). Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. J Endovasc Ther 11:695-704.
175. Siminiak T, R Kalawski, D Fiszer, O Jerzykowska, J Rzezniczak, N Rozwadowska and M Kurpisz. (2004). Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase 1 clinical study with 12 months of follow-up. Am Heart J 148:531-537.
176. Siminiak T, D Fiszer, O Jerzykowska, B Grygielska, N Rozwadowska, P Kalmucki and M Kurpisz. (2005). Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 26:1188-1195.
177. Siminiak T, D Fiszer, O Jerzykowska, B Grygielska, P Kalmucki and M Kurpisz. (2003). Percutaneous autologous myoblast transplantation in the treatment of post-infarction myocardial contractility impairment - report on two cases. Kardiol Pol 59:492-501.
178. Smits PC, RJ van Geuns, D Poldermans, M Bountioukos, EE Onderwater, CH Lee, AP Maat and PW Serruys. (2003). Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42:2063-2069.
179. Tambara K, Y Sakakibara, G Sakaguchi, F Lu, GU Premaratne, X Lin, K Nishimura and M Komeda. (2003). Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 108(Suppl 1):II259-II263.
180. Hagege AA, C Carrion, P Menasche, JT Vilquin, D Duboc, JP Marolleau, M Desnos and P Bruneval. (2003). Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361: 491-492.
181. Menasche P, AA Hagege, JT Vilquin, M Desnos, E Abergel, B Pouzet, A Bel, S Sarateanu, M Scorsin, K Schwartz, P Bruneval, M Benbunan, JP Marolleau and D Duboc. (2003). Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41:1078-1083.
182. Mege RM, D Goudou, C Diaz, M Nicolet, L Garcia, G Geraud and F Rieger. (1992). N-cadherin and N-CAM in myoblast fusion: compared localisation and effect of blockade by peptides and antibodies. J Cell Sci 103(Pt 4):897-906.
183. Mege RM, D Goudou, C Giaume, M Nicolet and F Rieger. (1994). Is intercellular communication via gap junctions required for myoblast fusion? Cell Adhes Commun 2:329-343.
184. MacCalman CD, N Bardeesy, PC Holland and OW Blaschuk. (1992). Noncoordinate developmental regulation of N-cadherin, N-CAM, integrin, and fibronectin mRNA levels during myoblast terminal differentiation. Dev Dynam 195:127-132.
185. El Oakley RM, OC Ooi, A Bongso and MH Yacoub. (2001). Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart. Ann Thorac Surg 71:1724-1733.
186. Tolmachov O, YL Ma, M Themis, P Patel, H Spohr, KT Macleod, ND Ullrich, Y Kienast, C Coutelle and NS Peters. (2006). Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro. BMC Cardiovasc Disord 6:25.
187. Azarnoush K, A Maurel, L Sebbah, C Carrion, A Bissery, C Mandet, J Pouly, P Bruneval, AA Hagege and P Menasche. (2005). Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor lalpha. J Thorac Cardiovasc Surg 130:173-179.
188. Haider HK, L Ye, S Jiang, R Ge, PK Law, T Chua, P Wong and EK Sim. (2004). Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor. J Mol Med 82:539-549.
189. Tambara K, GU Premaratne, G Sakaguchi, N Kanemitsu, X Lin, H Nakajima, Y Sakakibara, Y Kimura, M Yamamoto, Y Tabata, T Ikeda and M Komeda. (2005). Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft. Circulation 112:1129-1134.
190. Carvalho KA, LC Guarita-Souza, CL Rebelatto, AC Senegaglia, P Hansen, JG Mendonca, CC Cury, JC Francisco and PR Brofman. (2004). Could the coculture of skeletal myoblasts and mesenchymal stem cells be a solution for postinfarction myocardial scar? Transplant Proc 36:991-992.
191. Ott HC, R Kroess, N Bonaros, R Marksteiner, E Margreiter, T Schachner, G Laufer and S Hering. (2005). Intramyocardial microdepot injection increases the efficacy of skeletal myoblast transplantation. Eur J Cardiothorac Surg 27:1017-1021.
192. Brasselet C, MC Morichetti, E Messas, C Carrion, A Bissery, P Bruneval, JT Vilquin, A Lafont, AA Hagege, P Menasche and M Desnos. (2005). Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. Eur Heart J 26:1551-1556.
193. Premaratne GU, K Tambara, M Fujita, X Lin, N Kanemitsu, S Tomita, G Sakaguchi, H Nakajima, T Ikeda and M Komeda. (2006). Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction. Circ J 70:1184-1189.
194. Weissman IL. (2000). Stem cells: units of development, units of regeneration, and units in evolution. Cell 100:157-168.
195. Shi Q, S Rafii, MH Wu, ES Wijelath, C Yu, A Ishida, Y Fujita, S Kothari, R Mohle, LR Sauvage, MA Moore, RF Storb and WP Hammond. (1998). Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362-367.
196. Takahashi T, C Kalka, H Masuda, D Chen, M Silver, M Kearney, M Magner, JM Isner and T Asahara. (1999). Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Med 5:434-438.
197. Pereira RF, KW Halford, MD O'Hara, DB Leeper, BP Sokolov, MD Pollard, O Bagasra and DJ Prockop. (1995). Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 92:4857-4861.
198. Lagasse E, H Connors, M Al Dhalimy, M Reitsma, M Dohse, L Osborne, X Wang, M Finegold, IL Weissman and M Grompe. (2000). Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nature Med 6:1229-1234.
199. Petersen BE, WC Bowen, KD Patrene, WM Mars, AK Sullivan, N Murase, SS Boggs, JS Greenberger and JP Goff. (1999). Bone marrow as a potential source of hepatic oval cells. Science 284:1168-1170.
200. Theise ND, M Nimmakayalu, R Gardner, PB Illei, G Morgan, L Teperman, O Henegariu and DS Krause. (2000). Liver from bone marrow in humans. Hepatology 32:11-16.
201. Bittner RE, C Schofer, K Weipoltshammer, S Ivanova, B Streubel, E Hauser, M Freilinger, H Hoger, A Elbe-Burger and F Wachtler. (1999). Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl) 199:391-396.
202. Ferrari G, G Cusella-De Angelis, M Coletta, E Paolucci, A Stornaiuolo, G Cossu and F Mavilio. (1998). Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530.
203. Horwitz EM, DJ Prockop, LA Fitzpatrick, WW Koo, PL Gordon, M Neel, M Sussman, P Orchard, JC Marx, RE Pyeritz and MK Brenner. (1999). Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nature Med 5:309-313.
204. Mezey E, KJ Chandross, G Harta, RA Maki and SR McKercher. (2000). Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290:1779-1782.
205. Eglitis MA and E Mezey. (1997). Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA 94:4080-4085.
206. Orlic D. (2002). Stem cell repair in ischemic heart disease: an experimental model. Int J Hematol 76(Suppl 1):144-145.
207. Deb A, S Wang, KA Skelding, D Miller, D Simper and NM. Caplice. (2003). Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation 107:1247-1249.
208. Deb A, SH Wang, K Skelding, D Miller, D Simper and NM Caplice. (2005). Bone marrow-derived myofibroblasts are present in adult human heart valves. J Heart Valve Dis 14:674-678.
209. Tomoda H and N Aoki. (2003). Bone marrow stimulation and left ventricular function in acute myocardial infarction. Clin Cardiol 26:455-457.
210. Wollert KC, GP Meyer, J Lotz, S Ringes-Lichtenberg, P Lippolt, C Breidenbach, S Fichtner, T Korte, B Hornig, D Messinger, L Arseniev, B Hertenstein, A Ganser and H Drexler. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141-148.
211. Janssens S, C Dubois, J Bogaert, K Theunissen, C Deroose, W Desmet, M Kalantzi, L Herbots, P Sinnaeve, J Dens, J Maertens, F Rademakers, S Dymarkowski, O Gheysens, J Van Cleemput, G Bormans, J Nuyts, A Belmans, L Mortelmans, M Boogaerts and F Van de Werf. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367:113-121.
212. Nyolczas N, M Gyongyosi, G Beran, M Dettke, S Graf, H Sochor, G Christ, I Edes, L Balogh, KT Krause, K Jaquet, KH Kuck, I Benedek, T Hintea, R Kiss, I Preda, V Kotevski, H Pejkov, D Dudek, G Heba, C Sylven, S Charwat, R Jacob, G Maurer, I Lang and D Glogar. (2007). Design and rationale for the myocardial stem cell administration after acute myocardial infarction (MYSTAR) study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction. Am Heart J 153:212-217.
213. Jyotsna M, GK Vemuganti, P Reddy and KS Chandra. (2006). Autologous bone marrow-derived progenitor cell myocardial delivery for recent myocardial infarction patients following early angioplasty: results from a pilot study. Cardiovasc Revasc Med 7:217-221.
214. Bokeriia LA, I Buziashvili, ST Matskeplishvili and DK Kamardinov. (2004). [First experience with the use of bone marrow stem cells for regeneration therapy of ischemic heart disease.] Kardiologiia 44:16-22.
215. Stamm C, B Westphal, HD Kleine, M Petzsch, C Kittner, H Klinge, C Schumichen, CA Nienaber, M Freund and G Steinhoff. (2003). Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361:45-46.
216. Archundia A, JL Aceves, M Lopez-Hernandez, M Alvarado, E Rodriguez, QG Diaz, A Paez, FM Rojas and LF Montano. (2005). Direct cardiac injection of G-CSF mobilized bone-marrow stem-cells improves ventricular function in old myocardial infarction. Life Sci 78:279-283.
217. Liu J, Q Hu, Z Wang, C Xu, X Wang, G Gong, A Mansoor, J Lee, M Hou, L Zeng, JR Zhang, M Jerosch-Herold, T Guo, RJ Bache and J Zhang. (2004). Autologous stem cell transplantation for myocardial repair. Am J Physiol Heart Circ Physiol 287:H501-H511.
218. Weissman IL. (2000). Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287:1442-1446.
219. Orlic D, J Kajstura, S Chimenti, F Limana, I Jakoniuk, F Quaini, B Nadal-Ginard, DM Bodine, A Leri and P Anversa. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98:10344-10349.
220. Goodell MA, M Rosenzweig, H Kim, DF Marks, M DeMaria, G Paradis, SA Grupp, CA Sieff, RC Mulligan and RP Johnson. (1997). Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Med 3:1337-1345.
221. Meeson AP, TJ Hawke, S Graham, N Jiang, J Elterman, K Hutcheson, JM Dimaio, TD Gallardo and DJ Garry. (2004). Cellular and molecular regulation of skeletal muscle side population cells. Stem Cells 22:1305-1320.
222. Jackson KA, SM Majka, H Wang, J Pocius, CJ Hartley, MW Majesky, ML Entman, LH Michael, KK Hirschi and MA Goodell. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107:1395-1402.
223. Wagers AJ, RI Sherwood, JL Christensen and IL Weissman. (2002). Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297:2256-2259.
224. Murry CE, MH Soonpaa, H Reinecke, H Nakajima, HO Nakajima, M Rubart, KB Pasumarthi, JI Virag, SH Bartelmez, V Poppa, G Bradford, JD Dowell, DA Williams and LJ Field. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668.
225. Ratajczak MZ, M Kucia, M Majka, R Reca and J Ratajczak. (2004). Heterogeneous populations of bone marrow stem cells - are we spotting on the same cells from the different angles? Folia Histochem Cytobiol 42:139-146.
226. Hunting CB, WA Noort and JJ Zwaginga. (2005). Circulating endothelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization. Vox Sang 88:1-9.
227. Rabelink TJ, HC de Boer, EJ de Koning and AJ van Zonneveld. (2004). Endothelial progenitor cells: more than an inflammatory response? Arterioscler Thromb Vasc Biol 24:834-838.
228. Urbich C and S Dimmeler. (2004). Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 14:318-322.
229. Wakitani S, T Saito and AI Caplan. (1995). Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18: 1417-1426.
230. Asahara T, T Murohara, A Sullivan, M Silver, ZR van der, T Li, B Witzenbichler, G Schatteman and JM Isner. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
231. Hristov M, W Erl and PC Weber. (2003). Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23:1185-1189.
232. Deutsch V, H Shmilovich, A Abashidze, H Miller, G Keren, D Katz and J George, (2005). Comparative analysis of methods for assessment of circulating endothelial progenitor cells indicated hetrogeneity of sub-populations at varius stages of differentiation. J Thromb Haem 3:OR139
233. Iwaguro H, J Yamaguchi, C Kalka, S Murasawa, H Masuda, S Hayashi, M Silver, T Li, JM Isner and T Asahara. (2002). Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105:732-738.
234. Kawada H, J Fujita, K Kinjo, Y Matsuzaki, M Tsuma, H Miyatake, Y Muguruma, K Tsuboi, Y Itabashi, Y Ikeda, S Ogawa, H Okano, T Hotta, K Ando and K Fukuda. (2004). Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104:3581-3587.
235. Chen LB, XB Jiang and L Yang. (2004). Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 10:3016-3020.
236. Jager M, M Sager, A Knipper, O Degistirici, J Fischer, G Kogler, P Wernet and R Krauspe. (2004). [In vivo and in vitro bone regeneration from cord blood derived mesenchymal stem cells]. Orthopade 33:1361-1372.
237. Kang XQ, WJ Zang, TS Song, XL Xu, XJ Yu, DL Li, KW Meng, SL Wu and ZY Zhao. (2005). Rat bone marrow mesenchymal stem cells differentiate into hepatocytes in vitro. World J Gastroenterol 11:3479-3484.
238. Kihara T, A Oshima, M Hirose and H Ohgushi. (2004). Three-dimensional visualization analysis of in vitro cultured bone fabricated by rat marrow mesenchymal stem cells. Biochem Biophys Res Commun 316:943-948.
239. Lee KD, TK Kuo, J Whang-Peng, YF Chung, CT Lin, SH Chou, JR Chen, YP Chen and OK Lee. (2004). In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40:1275-1284.
240. Li S, D Huang, X Lu, J Liu, M Sun, Y Li, J Cheng, H Bu and C Liang. (2003). [Study on rabbit mesenchymal stem cells differentiation to the adipogenic or osteogenic lineage in vitro]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 20:209-213.
241. Rojas M, J Xu, CR Woods, AL Mora, W Spears, J Roman and KL Brigham. (2005). Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33:145-152.
242. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
243. Prockop DJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
244. Anjos-Afonso F, EK Siapati and D Bonnet. (2004). In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 117:5655-5664.
245. Airey JA, G Almeida-Porada, EJ Colletti, CD Porada, J Chamberlain, M Movsesian, JL Sutko and ED Zanjani. (2004). Human mesenchymal stem cells form Purkinje fibers in fetal sheep heart. Circulation 109:1401-1407.
246. Abedin M, Y Tintut and LL Demer. (2004). Mesenchymal stem cells and the artery wall. Circ Res 95:671-676.
247. Song L and RS Tuan. (2004). Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 18:980-982.
248. Tropel P, D Noel, N Platet, P Legrand, AL Benabid and F Berger. (2004). Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 295:395-406.
249. Beyth S, Z Borovsky, D Mevorach, M Liebergall, Z Gazit, H Asian, E Galun and J Rachmilewitz. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214-2219.
250. Bartholomew A, C Sturgeon, M Siatskas, K Ferrer, K Mcintosh, S Patil, W Hardy, S Devine, D Ucker, R Deans, A Moseley and R Hoffman. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48.
251. Tse WT, JD Pendleton, WM Beyer, MC Egalka and EC Guinan. (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75:389-397.
252. Schachinger V, B Assmus, MB Britten, J Honold, R Lehmann, C Teupe, ND Abolmaali, TJ Vogl, WK Hofmann, H Martin, S Dimmeler and AM Zeiher. (2004). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44:1690-1699.
253. Britten MB, ND Abolmaali, B Assmus, R Lehmann, J Honold, J Schmitt, TJ Vogl, H Martin, V Schachinger, S Dimmeler and AM Zeiher. (2003). Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108: 2212-2218.
254. Assmus B, V Schachinger, C Teupe, M Britten, R Lehmann, N Dobert, F Grunwald, A Aicher, C Urbich, H Martin, D Hoelzer, S Dimmeler and AM Zeiher. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009-3017.
255. Ziegelhoeffer T, B Fernandez, S Kostin, M Heil, R Voswinckel, A Helisch and W Schaper. (2004). Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94:230-238.
256. Vulliet PR, M Greeley, SM Halloran, KA MacDonald and MD Kittleson. (2004). Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363:783-784.
257. Amado LC, AP Saliaris, KH Schuleri, M St John, JS Xie, S Cattaneo, DJ Durand, T Fitton, JQ Kuang, G Stewart, S Lehrke, WW Baumgartner, BJ Martin, AW Heldman and JM Hare. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102: 11474-11479.
258. Poh KK, E Sperry, RG Young, T Freyman, KG Barringhaus and CA Thompson. (2006). Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: Safety of a high dose, "off-the-shelf," cellular cardiomyoplasty strategy. Int J Cardiol 117:360-364.
259. Chen SL, WW Fang, F Ye, YH Liu, J Qian, SJ Shan, JJ Zhang, RZ Chunhua, LM Liao, S Lin and JP Sun. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92-95.
260. Florenzano F and JJ Minguell. (2005). Autologous mesenchymal stem cell transplantation after acute myocardial infarction. Am J Cardiol 95:435.
261. Gojo S, N Gojo, Y Takeda, T Mori, H Abe, S Kyo, J Hata and A Umezawa. (2003). In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 288:51-59.
262. Jaquet K, KT Krause, J Denschel, P Faessler, M Nauerz, S Geidel, S Boczor, C Lange, N Stute, A Zander and KH Kuck. (2005). Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism? Stem Cells Dev 14:299-309.
263. Claycomb WC. (1992). Control of cardiac-muscle cell-division. Trends Cardiovasc Med 2:231-236.
264. Olivetti G, E Cigola, R Maestri, D Corradi, C Lagrasta, SR Gambert and P Anversa. (1996). Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J Mol Cell Cardiol 28: 1463-1477.
265. Kajstura J, A Leri, N Finato, C Di Loreto, CA Beltrami and P Anversa. (1998). Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 95:8801-8805.
266. Mazhari R and JM Hare. (2007). Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nature Clin Pract Cardiovasc Med 4(Suppl 1):S21-S26.
267. Beltrami AP, L Barlucchi, D Torella, M Baker, F Limana, S Chimenti, H Kasahara, M Rota, E Musso, K Urbanek, A Leri, J Kajstura, B Nadal-Ginard and P Anversa. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776.
268. Leri A, J Kajstura and P Anversa. (2005). Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 85:1373-1416.
269. Matsuura K, T Nagai, N Nishigaki, T Oyama, J Nishi, H Wada, M Sano, H Toko, H Akazawa, T Sato, H Nakaya, H Kasanuki and I Komuro. (2004). Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279:11384-11391.
270. Quaini F, K Urbanek, AP Beltrami, N Finato, CA Beltrami, B Nadal-Ginard, J Kajstura, A Leri and P Anversa. (2002). Chimerism of the transplanted heart. N Engl J Med 346:5-15.
271. Urbanek K, D Torella, F Sheikh, AD Angelis, D Nurzynska, F Silvestri, CA Beltrami, R Bussani, AP Beltrami, F Quaini, R Bolli, A Leri, J Kajstura and P Anversa. (2005). Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA 102:8692-8697.
272. Smith RR, L Barile, HC Cho, MK Leppo, JM Hare, E Messina, A Giacomello, MR Abraham and E Marban. (2007). Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115:896-908.
273. Oyama T, T Nagai, H Wada, AT Naito, K Matsuura, K Iwanaga, T Takahashi, M Goto, Y Mikami, N Yasuda, H Akazawa, A Uezumi, S Takeda and I Komuro. (2007). Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol 176:329-341.
274. Strauer BE, M Brehm, T Zeus, N Gattermann, A Hernandez, RV Sorg, G Kogler and P Wernet. (2001). [Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction]. Dtsch Med Wochenschr 126:932-938.
275. Glaser R, MM Lu, N Narula and JA Epstein. (2002). Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 106:17-19.
276. Laflamme MA and CE Murry. (2005). Regenerating the heart. Nature Biotechnol 23:845-856.